期刊文献+

胰岛素样生长因子I基因启动子区CA重复序列多态性与2型糖尿病的相关性 被引量:2

Association of CA repeats polymorphism in the promoter region of the insulin-like growth factor- I gene with type 2 diabetes
原文传递
导出
摘要 目的 研究胰岛素样生长因子Ⅰ(IGF-Ⅰ)基因启动子区CA重复序列多态性与2型糖尿病发病的相关性.方法 采用口服葡萄糖耐量试验筛选出性别、年龄匹配的新诊2型糖尿病患者147例,正常糖耐量者159例,将抽提的基因组DNA应用聚合酶链反应扩增,再通过选择不同长度的纯合子样本测序确定CA重复的次数,以确定等位基因,分析其与2型糖尿病发病的相关性.结果 CA重复各基因型分布在2型糖尿病组及正常糖耐量组无显著差异.携带≥(CA)20等位基因的受试者较不携带该种等位基因的受试者具有显著低的血尿酸[(4.18±1.25对4.63±1.36)mg/dl,P=0.03].结论 携带CA重复次数≥20的等位基因可能是2型糖尿病的保护因子. Objective To investigate the association of CA repeats polymorphism in the promoter region of human IGF-I gene with type 2 diabetes in narthen Han nationality. Methods Gender-age matched subjects with type 2 diabetes and normal glucose tolerance (NGT) were enrolled for this study, 147 subjects in type 2 diabetes group and 159 subjects in NGT group. Genomic DNA was extracted by standard methods. PCR, Genescan,Genotyper, and direct sequencing were conducted to screen CA repeats polymorphism in the promoter region of the human IGF-I gene. Results No significant association was observed between any ( CA), repeat genotype and type 2 diabetes. A lowered serum uric acid was seen in genotypes that included alleles with larger than (CA) 20 repeats [(4.18 ± 1.25 vs 4.63 ± 1.36) mg/dl, P = 0.03]. Conclusion Alleles with larger than (CA) 20 repeats may be a protective factor for type 2 diabetes.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2010年第12期1042-1044,共3页 Chinese Journal of Endocrinology and Metabolism
关键词 胰岛素样生长因子Ⅰ 多态现象 遗传 糖尿病 2型 尿酸 Insulin-like growth factor-Ⅰ Polymorphism Diabetes mellitus, type 2 Uric acid
  • 相关文献

参考文献20

  • 1Rinderknecht E,Humbel RE.The amino acid sequence of human insulin like growth factor Ⅰ and its structural homology,with proinsulin.J Biol Chem,1978,253:2769-2776.
  • 2Dunger DB,Ong KKL,Sandhu MS.Serum insulin-like growth faotorⅠ levels and potential risk of type 2 diabetes.Horm Res,2003,60(Suppl 3):131-135.
  • 3路聪哲.IGF-1与IGFBP-1在Graves病糖代谢中的作用[J].国外医学(内分泌学分册),2001,21(4):212-213. 被引量:17
  • 4Nielsen D,Hansen L.A common polymorphism in the promoter of the IGF-Ⅰ gene associates with increased fasting serum triglyceride levels in glucose-tolerant subjects.Clinical Biochemistry,2004,37:660-665.
  • 5Weber MM,Melmed S.Rat somatotroph insulin-like growth factor-Ⅱ (IGF-Ⅱ) signaling:role of the IGF-I receptor.Endocrinol,2001,144:251-256.
  • 6Cederholm J,Wibell L.Insulin release and peripheral sensitivity at the oral glucose tolerance test.Diabetes Res,1990,10:167-175.
  • 7McCarthy TL,Ji C.17βestradiol potentially suppresses cAMP-induced IGF-I gene activation in primary rat osteoblasts cultures.J Biol Chem,1997,272:18132-18139.
  • 8Tae HJ,Luo X,Kim KH.Roles of CCAAT/enhancer-binding protein and its binding site on repression and derepression of acetyl-CoA carboxylase gene.J Biol Chem,1994,269:10475-10484.
  • 9Gebhardt F,Zanker KS,Brandt B.Modulation of epidermal growth factor receptor gene transcription by a polymorphic dinucleotide repeat in intron 1.J Biol Chem,1999,274:13176-13180.
  • 10Vaessen N,Heutink P,Janssen JA,et al.Association between serum insulin-like growth factor-Ⅰ-Functional properties and risk for type 2 diabetes and myocardial infarction.Diabetes,2001,50:637-642.

二级参考文献134

共引文献52

同被引文献26

  • 1中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5230
  • 2杨巍,陈庆.2型糖尿病并发高尿酸血症的临床观察[J].现代临床医学,2007,33(4):282-283. 被引量:8
  • 3Singh M.Framingham equations overestimate risk of coronary heart disease mortality in British males.Evidence-based Health-care,2004,8:131-132.
  • 4Tatami R,Mabuchi H,Ueda K,et al.Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein angiographically determined coronary artery disease.Circulation,1981,64:1174-1184.
  • 5Schmidt MI,Watson RL,Duncan BB,et al.Clustering of dyslipidemia,hyperuricemia,diabetes,and hypertension and its association with fasting insulin and central and overall obesity in a general population.Metabolism,1996,45:699-706.
  • 6Grundy SM,Cleeman JI,Daniels SR,et al.Diagnosis and management of the metabolic syndrome.An American Heart Association/National Heart,Lung,and Blood Institute Scientific Statement.Circulation,2005,112:2735-2752.
  • 7Quinones GA,Natali A,Baldi S,et al.Effect of insulin on uric acid excretion in humans.Am J Physiol,1995,268:E1-E5.
  • 8Freedman DS,Williamson DF,Gunter EW,et al.Relation of serum uric acid to mortality and ischemic heart disease.The NHANES I Epidemiologic Follow-Up Study.Am J Epidemiol,1995,141:637-644.
  • 9Bengtsson C,Lapidus L,Stendahl C,et al.Hyperuricaemia and risk of cardiovascular disease and overall death.A 12-year follow-up of participants in the population study of women in Gothenburg,Sweden.Acta Med Scand,1988,224:549-555.
  • 10Ishizaka N,Ishizaka Y,Takahashi E,et al.Association between insulin resistance and carotid arteriosclerosis in subjects with normal fasting glucose and normal glucose tolerance.Arterioscler Thromb Vasc Biol,2003,23:295-301.

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部